Leakproof Connection Integrity Test For Devices Intended for Handling Hazardous Drugs
James A. Jorgenson, RPh, MS, FASHP

Leakproof Connection Integrity Test For Devices Intended for Handling Hazardous Drugs

University of Utah
James A. Jorgenson, RPh, MS, FASHP
Salt Lake City, Utah
2008

Objective

To determine if the ICU Medical System, B. Braun OnGuardTM System, Cardinal Health/Alaris System or PhaSeal® System connections are leak proof or have the potential to allow drugs to escape into the environment during the preparation and administration phases of hazardous drug handling.

Methods

Four transfer devices were tested:

  • The ICU Medical System (SpirosTM Male Connector & Clave® Connector)
  • The B. Braun OnGuardTM System (Vial Adaptor & Syringe Adaptor) by Teva Medical Ltd.
  • The Alaris System (SmartSite® Vented Vial Access Device & TexiumTM Male Luer) by Cardinal Health
  • The PhaSeal® System (Protector & Injector Luer Lock) by Carmel Pharma

A liquid with low pH was used as a substitute for active drug. Litmus paper was used as a pH indicator. Blue litmus paper turns red under acidic conditions.

Syringes were filled with fluid and injected into vials attached to the above transfer devices. After aspirating back and disconnecting, the connections of each device were pressed against litmus paper to detect the presence of any fluid.

Every component of each device was tested for 10 manipulations.

Results

Visible leakage occurred outside of the components on the ICU Medical System SpirosTM and Clave® connections, the B. Braun OnGuardTM System and the Cardinal Health/Alaris System during all manipulations.

No leakage was observed in any of the manipulations with the PhaSeal® System by Carmel Pharma.

Spiros™ Male Connector & Clave® by ICU Medical Inc.

B. Braun OnGuardâ„¢ Vial Adaptor & Syringe Adaptor by Teva Medical Ltd.

Alaris SmartSite® Vented Vial Access Device & Texiumâ„¢ Male Luer by Cardinal Health

Alaris SmartSite® Vented Vial Access Device & Texiumâ„¢ Male Luer by Cardinal Health

Related Clinical Studies

Independent
2024
#CSTD Preparation
#efficiency
#Pharmacist

Comparison of closed-system transfer devices to compound cytotoxic medicines in a hospital pharmacy compounding unit

Queensland Children’s Hospital Pharmacy Department
Contamination on inner walls of syringes used for compounding and administration of hazardous drugs
Peer-Reviewed
2025
#syringe-contamination

Contamination on Inner Walls of Syringes Used for Compounding and Administration of Hazardous Drugs

University Hospital Leuven
Peer-Reviewed
2024
#air-tight
#syringe unit
#syringe-contamination

An Assessment of Exposed Syringe Inner Walls as a Route of Exposure from Hazardous Drugs

UNC Eshelman School of Pharmacy

References